Press releases – Page 3

31 January, 2014

Regulatory

NeuroVive rights issue 270% oversubscribed

NeuroVive Pharmaceutical AB (publ) has completed the rights issue approved by an Extraordinary General Meeting on 13 December 2013. The subscription period was 13-27 January 2014. The rights issue was ...

29 January, 2014

Regulatory

NeuroVive extends partnership agreement with InVentiv Health to prepare for upcoming market launch

Agreement expands consulting services acquired by NeuroVive, with the possibility of a broader partnership for development and commercialization services.

23 January, 2014

Regulatory

Supplementary subscription undertakings by transfer of subscription rights

One of NeuroVive's largest shareholders, Baulos Capital (formerly Private Placement Sprl) and Dr. Guo Weicheng, co-founder of Sihuan Pharmaceuticals (the company's partner in China) have undertaken to ...

22 January, 2014

Regulatory

Last day of trading in subscription rights in the ongoing rights issue

NeuroVive Pharmaceutical AB (publ) today announced that 22 January 2014 is the last day of trading in subscription rights in the company's ongoing new issue. The subscription period will continue unti ...

15 January, 2014

Regulatory

Senior managers’ and Directors’ subscriptions in new issue

Many Directors and senior managers intend to participate in NeuroVive's current rights issue.

8 January, 2014

Regulatory

NeuroVive Pharmaceutical AB (publ) publishes prospectus

On 20 November 2013, the Board of Directors of NeuroVive Pharmaceutical AB (publ) ("NeuroVive") decided to execute a rights issue. Coincident with this new share issue, NeuroVive has published a prosp ...